Clinical trial Recruiting at 1 site Interventional Ages 18 and up

rTMS-primed self-controlled practice for people with Parkinson’s disease

Official title: Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice on Motor Behavior, Psychosocial Functioning, and Neurophysiological Mechanisms in People With Parkinson's Disease

Run by National Taiwan University Hospital · NCT07832695 · Data updated 2026-11-12

This study tests whether priming motor training with rTMS and letting people with Parkinson’s control their practice improves motor learning and motivation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei, Zhongzheng Dist.)
StatusRecruiting
StartedSeptember 23, 2026
Main results expectedDecember 31, 2031
Study endsDecember 31, 2032
Registry record updatedSeptember 22, 2026
Trial IDNCT07832695 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson’s disease who can stand/walk for 10 minutes and have Montreal Cognitive Assessment score ≥ 24.

Probably not a fit

Patients with contraindications to TMS or unstable medical conditions, or those unable to follow study instructions, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study explores whether combining repetitive transcranial magnetic stimulation (rTMS) with self-controlled motor training enhances rehabilitation outcomes in Parkinson’s disease. Participants will receive rTMS priming before or during physical therapy that allows self-selected training parameters, aiming to improve motor learning and engagement. The trial investigates whether targeting different cortical areas yields different benefits and whether the approach is feasible in an outpatient setting. Eligible adults with Parkinson’s disease must be able to stand/walk for 10 minutes and have adequate cognitive function. Safety considerations include exclusion of individuals with contraindications to TMS or other neurological/medical conditions that could confound results.

Why it matters

Potential benefit: If successful, patients may experience better motor learning, greater motivation, and improved rehabilitation responses.

How similar studies have gone: Previous evidence supports using self-controlled training and neuromodulation to boost motor learning, though combining rTMS priming with self-controlled practice is still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosed of PD by neurologists and age above 18 years old
* able to follow the researcher's instruction (the Montreal Cognitive Assessment ≥ 24)
* able to stand and walk independently for 10 minutes with or without assistive devices

Exclusion Criteria:

* have neurological disorders other than PD (e.g., Parkinson plus syndrome, cognitive impairment, dementia, stroke)
* have contraindications to receive TMS, such as a pacemaker or deep brain stimulator implanted in the body
* a self-history of seizure or a family history of epilepsy
* pregnancy
* unstable medical conditions that is not under control

Where it's running

  • School and Graduate Institute of Physical Therapy
    Taipei, Zhongzheng Dist., Taiwan
    Recruiting

Study contacts

  • Principal investigator: Graduate Institute of Physical Therapy — National Taiwan University
  • Study coordinator: Ya-Yun Lee, PhD
  • Email: yayunlee@ntu.edu.tw
  • Phone: +886-2-33668155

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.